These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 21896536
1. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Mogensen UM, Ersbøll M, Andersen M, Andersson C, Hassager C, Torp-Pedersen C, Gustafsson F, Køber L. Eur J Heart Fail; 2011 Nov; 13(11):1216-23. PubMed ID: 21896536 [Abstract] [Full Text] [Related]
2. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Badheka AO, Rathod A, Kizilbash MA, Bhardwaj A, Ali O, Afonso L, Jacob S. Am J Cardiol; 2011 Nov 01; 108(9):1283-8. PubMed ID: 21855829 [Abstract] [Full Text] [Related]
3. Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure Registry. Holmström A, Sigurjonsdottir R, Edner M, Jonsson A, Dahlström U, Fu ML. Int J Cardiol; 2013 Sep 10; 167(6):2747-52. PubMed ID: 22805544 [Abstract] [Full Text] [Related]
4. Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study). Magaña-Serrano JA, Almahmeed W, Gomez E, Al-Shamiri M, Adgar D, Sosner P, Herpin D, I PREFER Investigators. Am J Cardiol; 2011 Nov 01; 108(9):1289-96. PubMed ID: 22000627 [Abstract] [Full Text] [Related]
5. A review of heart failure management in the elderly population. Cheng JW, Nayar M. Am J Geriatr Pharmacother; 2009 Oct 01; 7(5):233-49. PubMed ID: 19948300 [Abstract] [Full Text] [Related]
7. Clinical characteristics and one-year survival in heart failure patients more than 85 years of age compared with younger. Conde-Martel A, Formiga F, Pérez-Bocanegra C, Armengou-Arxé A, Muela-Molinero A, Sánchez-Sánchez C, Diez-Manglano J, Montero-Pérez-Barquero M. Eur J Intern Med; 2013 Jun 01; 24(4):339-45. PubMed ID: 23385010 [Abstract] [Full Text] [Related]
15. Diabetes in heart failure: prevalence and impact on outcome in the population. From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL. Am J Med; 2006 Jul 01; 119(7):591-9. PubMed ID: 16828631 [Abstract] [Full Text] [Related]
17. Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age. Ruwald MH, Hansen ML, Lamberts M, Hansen CM, Numé AK, Vinther M, Køber L, Torp-Pedersen C, Hansen J, Gislason GH. Am J Cardiol; 2013 Nov 15; 112(10):1610-5. PubMed ID: 24035171 [Abstract] [Full Text] [Related]